HC Wainwright & Co. Reiterates Buy on Arrowhead Pharma, Maintains $100 Price Target
HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Arrowhead Pharma (NASDAQ: ARWR ) with a Buy and maintains $100 price target.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.